Afandy Nathania Octaviani, Lock Hui Shan, Tay Laura, Yeo Audrey, Yew Suzanne, Leung Bernard P, Lim Wee Shiong
Health and Social Sciences, Singapore Institute of Technology, Singapore.
Department of Diagnostic Radiology, Khoo Teck Puat Hospital, Singapore.
J Frailty Sarcopenia Falls. 2021 Mar 1;6(1):25-31. doi: 10.22540/JFSF-06-025. eCollection 2021 Mar.
We aim to determine the association of monocyte chemotactic protein-1 (MCP-1) and dickkopft-1 (DKK-1) as potential biomarkers that may predict changes in body composition and physical performance in healthy older adults from Singapore.
Two-hundred community-dwelling older adults (mean age: 67.9 years; 68.5% females) were classified into elevated versus non-elevated groups based on quintile cut-offs of MCP-1 and DKK-1 levels (156.02 pg/mL and 606.31 pg/mL, respectively). Multiple linear regression was performed to examine the relationship between MCP-1 and DKK-1 with body composition and physical performance, adjusted for age, gender and ethnicity.
MCP-1 was significantly associated with higher fat mass, fat mass index, percentage body fat, waist circumference and trunk-limb ratio for fat mass (all p<0.01), and repeated chair stand (p=0.004). DKK-1 was not associated with body composition and physical performance measures. Utilising the Asian Working Group for Sarcopenia (AWGS) 2019 criteria, there were 39 (19.5%) sarcopenia and 161 (80.5%) non-sarcopenia participants respectively, with MCP-1 levels significantly higher in sarcopenia compared with non-sarcopenia (p=0.046), but not for DKK-1 (p=0.525).
Elevated MCP-1 are associated with changes in fat composition, physical performance and sarcopenia, suggesting its usefulness in identifying at-risk group with sarcopenic obesity.
我们旨在确定单核细胞趋化蛋白-1(MCP-1)和Dickkopf-1(DKK-1)作为潜在生物标志物的关联,这些标志物可能预测新加坡健康老年人身体成分和身体机能的变化。
根据MCP-1和DKK-1水平的五分位数切点(分别为156.02 pg/mL和606.31 pg/mL),将200名社区居住的老年人(平均年龄:67.9岁;68.5%为女性)分为升高组和非升高组。进行多元线性回归以检验MCP-1和DKK-1与身体成分和身体机能之间的关系,并对年龄、性别和种族进行了调整。
MCP-1与较高的脂肪量、脂肪量指数、体脂百分比、腰围和脂肪量的躯干-四肢比显著相关(均p<0.01),以及与重复坐立试验相关(p=0.004)。DKK-1与身体成分和身体机能指标无关。根据亚洲肌少症工作组(AWGS)2019年标准,分别有39名(19.5%)肌少症患者和161名(80.5%)非肌少症参与者,肌少症患者的MCP-1水平显著高于非肌少症患者(p=0.046),但DKK-1并非如此(p=0.525)。
MCP-1升高与脂肪成分变化、身体机能和肌少症相关,表明其在识别肌少症肥胖高危人群方面有用。